Overview of pharmacological interventions after traumatic brain injuries: impact on selected outcomes

References

• Centers for Disease Control and Prevention (CDC), Faul M, Xu L, Wald MM, Coronado VG. Traumatic brain injury in the United States: emergency department visits, hospitalizations and deaths. Atlanta (Georgia): Centers for Disease Control and Prevention; 2010.
   Google Scholar
• Wilson L, Stewart W, Dams-O’Connor K, Diaz-Arrastia R, Horton L, Menon DK, Polinder S. The chronic and evolving neurological consequences of traumatic brain injury. Lancet Neurol. 2017 Oct;16(10):813–25. doi:10.1016/S1474-4422(17)30279-X. Cited in PubMed PMID: 28920887. Epub 2017/ 09/19.eng.
   PubMed Web of Science ®Google Scholar
• Vallat-Azouvi C, Paillat C, Bercovici S, Morin B, Paquereau J, Charanton J, Ghout I, Azouvi P. Subjective complaints after acquired brain injury: presentation of the Brain Injury Complaint Questionnaire (BICoQ). J Neurosci Res. 2018 Apr;96(4):601–611. doi:10.1002/jnr.24180. Cited in PubMed PMID: 28976025.
   PubMed Web of Science ®Google Scholar
• *Meyer MJ, Megyesi J, Meythaler J, Murie-Fernandez M, Aubut JA, Foley N, Salter K, Bayley M, Marshall S, Teasell R. Acute management of acquired brain injury part II: an evidence-based review of pharmacological interventions. Brain Inj. 2010;24(5):706–21. Cited in PubMed PMID: 20376996. Epub 2010/ 04/10.eng.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Mahmood A, Chopp M. Animal models of traumatic brain injury. Nat Rev Neurosci. 2013 Feb;14(2):128–42. doi:10.1038/nrn3407. Cited in PubMed PMID: 23329160. Pubmed Central PMCID: PMC3951995. Epub 2013/01/19.eng.
   PubMed Web of Science ®Google Scholar
• Bouzat P, Francony G, Thomas S, Valable S, Mauconduit F, Fevre MC, Barbier EL, Bernaudin M, Lahrech H, Payen JF. Reduced brain edema and functional deficits after treatment of diffuse traumatic brain injury by carbamylated erythropoietin derivative. Crit Care Med. 2011 Sep;39(9):2099–105. doi:10.1097/CCM.0b013e31821cb7b2. Cited in PubMed PMID: 21552121. Epub 2011/ 05/10.eng.
   PubMed Web of Science ®Google Scholar
• Deselms H, Maggio N, Rubovitch V, Chapman J, Schreiber S, Tweedie D, Kim DS, Greig NH, Pick CG. Novel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development. J Neurosci Methods. 2016 Oct;15(272):69–76. doi:10.1016/j.jneumeth.2016.02.002. Cited in PubMed PMID: 26868733. Epub 2016/ 02/13.eng.
   Google Scholar
• Feng JF, Van KC, Gurkoff GG, Kopriva C, Olszewski RT, Song M, Sun S, Xu M, Neale JH, Yuen PW, et al.Post-injury administration of NAAG peptidase inhibitor prodrug, PGI-02776, in experimental TBI. Brain Res. 2011 Jun 13;1395:62–73. doi:10.1016/j.brainres.2011.04.022. Cited in PubMed PMID: 21565332. Pubmed Central PMCID: PMC3105192. Epub 2011/ 05/14.eng.
   PubMed Web of Science ®Google Scholar
• Shanks N, Greek R, Greek J.Are animal models predictive for humans? Philos Ethics Humanit Med. 2009 Jan 15;4:2. doi:10.1186/1747-5341-4-2. Cited in PubMed PMID: 19146696. Pubmed Central PMCID: PMC2642860. Epub 2009/ 01/17.eng.
   PubMedGoogle Scholar
• Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015 Jan 01;4:1. doi:10.1186/2046-4053-4-1. Cited inPubMed PMID: 25554246. Pubmed Central PMCID: PMC4320440. Epub 2015/ 01/03.eng.
   PubMed Web of Science ®Google Scholar
• Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. International journal of evidence-based healthcare. 2015 Sep;13(3):132–40. doi:10.1097/xeb.0000000000000055. Cited in PubMed PMID: 26360830.
   Google Scholar
• Gultekin R, Huang S, Clavisi O, Pattuwage L, Konig TC, Gruen R. Pharmacological interventions in traumatic brain injury: can we rely on systematic reviews for evidence? Injury. 2016 Mar;47(3):516–24. doi:10.1016/j.injury.2015.10.011. Cited in PubMed PMID: 26589595. Epub 2015/ 11/22.eng..
   PubMed Web of Science ®Google Scholar
• Sandel ME, Mysiw WJ. The agitated brain injured patient. part 1: definitions, differential diagnosis, and assessment. USA: Elsevier Inc.; 1996.
   Google Scholar
• Park S, Williams RA, Lee D. Effect of preferred music on agitation after traumatic brain injury. West J Nurs Res. 2016 Apr;38(4):394–410. doi:10.1177/0193945915593180. Cited in PubMed PMID: 26129873. Epub 2015/ 07/02.eng.
   PubMed Web of Science ®Google Scholar
• Aaronson A, Lloyd RB. Aggression after traumatic brain injury: a review of the current literature. Psychiatr Ann. 2015;45(8):422–26. doi:10.3928/00485713-20150803-08.
   Web of Science ®Google Scholar
• Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and associated methodologies. Health Info Libr J. 2009 Jun;26(2):91–108. doi:10.1111/j.1471-1842.2009.00848.x. Cited in PubMed PMID: 19490148. Epub 2009/ 06/06.eng.
   PubMed Web of Science ®Google Scholar
• *Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009 Oct;62(10):1006–12. doi:10.1016/j.jclinepi.2009.06.005. Cited in PubMed PMID: 19631508. Epub 2009/ 07/28.eng.
   PubMed Web of Science ®Google Scholar
• Levac D, Colquhoun H, O’Brien KK.Scoping studies: advancing the methodology. Implement Sci. 2010 Sep 20;5:69. doi:10.1186/1748-5908-5-69. Cited in PubMed PMID: 20854677. Pubmed Central PMCID: PMC2954944. Epub 2010/ 09/22.eng.
   PubMed Web of Science ®Google Scholar
• *Chelladurai Y, Stevens KA, Haut ER, Brotman DJ, Sharma R, Shermock KM, Kebede S, Singh S, Segal JB. Venous thromboembolism prophylaxis in patients with traumatic brain injury: a systematic review. F1000Research. 2013;2:132. doi:10.12688/f1000research. Cited in PubMed PMID: 25309725. Pubmed Central PMCID: PMC4184319. Epub 2013/ 01/01.eng.
   PubMedGoogle Scholar
• *Jamjoom AA, Jamjoom AB. Safety and efficacy of early pharmacological thromboprophylaxis in traumatic brain injury: systematic review and meta-analysis. J Neurotrauma. 2013 Apr 01;30(7):503–11. doi:10.1089/neu.2012.2584. Cited in PubMed PMID: 23517138. Epub 2013/ 03/23.eng.
   PubMed Web of Science ®Google Scholar
• *Reeves F, Batty L, Pitt V, Chau M, Pattuwage L, Gruen RL. Safety and efficacy of pharmacologic thromboprophylaxis following blunt head injury: a systematic review. J Trauma Acute Care Surg. 2013 Oct;75(4):642–56. doi:10.1097/TA.0b013e3182a12a45. Cited in PubMed PMID: 24064878. Epub 2013/ 09/26.eng.
   PubMed Web of Science ®Google Scholar
• *Shen X, Dutcher SK, Palmer J, Liu X, Kiptanui Z, Khokhar B, Al-Jawadi MH, Zhu Y, Zuckerman IH. A systematic review of the benefits and risks of anticoagulation following traumatic brain injury. J Head Trauma Rehabil. 2015 Jul–Aug;30(4):E29–37. doi:10.1097/HTR.0000000000000077. Cited in PubMed PMID: 24992639. Pubmed Central PMCID: PMC4282634. Epub 2014/ 07/06.eng.
   PubMed Web of Science ®Google Scholar
• *Singh S, Haut ER, Brotman DJ, Sharma R, Chelladurai Y, Shermock KM, Kebede S, Stevens KA, Prakasa KR, Shihab HM, Akande TO, Zeidan AM, Garcia LJ, Segal JB. AHRQ Comparative Effectiveness Reviews. Rockville (MD): Agency for Healthcare Research and Quality (US). 2013 [cited 2019 Jan 8]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK148555/.
   Google Scholar
• *Ker K, Roberts I, Shakur H, Coats TJ. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev. 2015;5:CD004896. Cited in PubMed PMID: 25956410. Epub 2015/ 05/10.eng.
   Google Scholar
• *Zehtabchi S, Abdel Baki SG, Falzon L, Nishijima DK. Tranexamic acid for traumatic brain injury: a systematic review and meta-analysis. Am J Emerg Med. 2014 Dec;32(12):1503–09. doi:10.1016/j.ajem.2014.09.023. Cited in PubMed PMID: 25447601. Pubmed Central PMCID: PMC4988127. Epub 2014/ 12/03.eng.
   PubMed Web of Science ®Google Scholar
• Levin HS, Diaz-Arrastia RR. Diagnosis, prognosis, and clinical management of mild traumatic brain injury. Lancet Neurol. 2015 May;14(5):506–17. doi:10.1016/S1474-4422(15)00002-2. Cited in PubMed PMID: 25801547. Epub 2015/ 03/25.eng.
   PubMed Web of Science ®Google Scholar
• *Batchelor JS, Grayson A. A meta-analysis to determine the effect of anticoagulation on mortality in patients with blunt head trauma. Br J Neurosurg. 2012 Aug;26(4):525–30. doi:10.3109/02688697.2011.650736. Cited in PubMed PMID: 22324438. Epub 2012/ 02/14.eng.
   PubMed Web of Science ®Google Scholar
• *Zafar SN, Iqbal A, Farez MF, Kamatkar S, de Moya MA. Intensive insulin therapy in brain injury: a meta-analysis. J Neurotrauma. 2011 Jul;28(7):1307–17. doi:10.1089/neu.2010.1724. Cited in PubMed PMID: 21534731. Epub 2011/ 05/04.eng.
   PubMed Web of Science ®Google Scholar
• *Lu J, Gary KW, Neimeier JP, Ward J, Lapane KL. Randomized controlled trials in adult traumatic brain injury. Brain Inj. 2012;26(13–14):1523–48. doi:10.3109/02699052.2012.722257. Cited in PubMed PMID: 23163248. Epub 2012/ 11/21.eng.
   PubMed Web of Science ®Google Scholar
• *Ma J, Huang S, Qin S, You C. Progesterone for acute traumatic brain injury. Cochrane Database Syst Rev. 2012 Oct;17(10):CD008409. Cited in PubMed PMID: 23076947. Epub 2012/ 10/19.eng.
   Google Scholar
• *Radosevich JJ, Patanwala AE, Erstad BL. Emerging pharmacological agents to improve survival from traumatic brain injury. Brain Inj. 2013;27(13–14):1492–99. doi:10.3109/02699052.2013.823658. Cited in PubMed PMID: 24205899. Epub 2013/ 11/12.eng.
   PubMed Web of Science ®Google Scholar
• *Roberts DJ, Hall RI, Kramer AH, Robertson HL, Gallagher CN, Zygun DA. Sedation for critically ill adults with severe traumatic brain injury: a systematic review of randomized controlled trials. Crit Care Med. 2011 Dec;39(12):2743–51. doi:10.1097/CCM.0b013e318228236f. Cited in PubMed PMID: 22094498. Epub 2011/ 11/19.eng.
   PubMed Web of Science ®Google Scholar
• *Lazaridis C, Neyens R, Bodle J, DeSantis SM. High-osmolarity saline in neurocritical care: systematic review and meta-analysis. Crit Care Med. 2013 May;41(5):1353–60. doi:10.1097/CCM.0b013e31827ca4b3. Cited in PubMed PMID: 23591212. Epub 2013/ 04/18.eng.
   PubMed Web of Science ®Google Scholar
• *Rickard AC, Smith JE, Newell P, Bailey A, Kehoe A, Mann C. Salt or sugar for your injured brain? A meta-analysis of randomised controlled trials of mannitol versus hypertonic sodium solutions to manage raised intracranial pressure in traumatic brain injury. Emerg Med J. 2014 Aug;31(8):679–83. doi:10.1136/emermed-2013-202679. Cited in PubMed PMID: 23811861. Epub 2013/ 07/03.eng.
   PubMed Web of Science ®Google Scholar
• *Tan PG, Cincotta M, Clavisi O, Bragge P, Wasiak J, Pattuwage L, Gruen RL. Review article: prehospital fluid management in traumatic brain injury. Emerg Med Australas. 2011 Dec;23(6):665–76. doi:10.1111/j.1742-6723.2011.01455.x. Cited in PubMed PMID: 22151665. Epub 2011/ 12/14.eng.
   PubMed Web of Science ®Google Scholar
• *Wakai A, McCabe A, Roberts I, Schierhout G. Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev. 2013 Aug;05(8):CD001049. Cited in PubMed PMID: 23918314. Epub 2013/ 08/07.eng.
   Google Scholar
• *Langham J, Goldfrad C, Teasdale G, Shaw D, Rowan K. Calcium channel blockers for acute traumatic brain injury. Cochrane Database Syst Rev. 2003; 4, CD000565.
   PubMedGoogle Scholar
• *Murray GD, Teasdale GM, Schmitz H. Nimodipine in traumatic subarachnoid haemorrhage: a re-analysis of the HIT I and HIT II trials. Acta Neurochir (Wien). 1996;138(10):1163–67. Cited in PubMed PMID: 8955434. Epub 1996/ 01/01.eng.
   PubMed Web of Science ®Google Scholar
• *Vergouwen MD, Vermeulen M, Roos YB. Effect of nimodipine on outcome in patients with traumatic subarachnoid haemorrhage: a systematic review. Lancet Neurol. 2006 Dec;5(12):1029–32. doi:10.1016/S1474-4422(06)70582-8. Cited in PubMed PMID: 17110283. Epub 2006/ 11/18.eng.
   PubMed Web of Science ®Google Scholar
• *Xu GZ, Wang MD, Liu KG, Bai YA, Wu W, Li W. A meta-analysis of treating acute traumatic brain injury with calcium channel blockers. Brain Res Bull. 2013 Oct;99:41–47. doi:10.1016/j.brainresbull.2013.09.011. Cited in PubMed PMID: 24099981. Epub 2013/ 10/09.eng.
   PubMed Web of Science ®Google Scholar
• *Wheaton P, Mathias JL, Vink R. Impact of pharmacological treatments on cognitive and behavioral outcome in the postacute stages of adult traumatic brain injury: a meta-analysis. J Clin Psychopharmacol. 2011 Dec;31(6):745–57. doi:10.1097/JCP.0b013e318235f4ac. Cited in PubMed PMID: 22020351. Epub 2011/ 10/25.eng.
   PubMed Web of Science ®Google Scholar
• *Alali AS, McCredie VA, Golan E, Shah PS, Nathens AB. Beta blockers for acute traumatic brain injury: a systematic review and meta-analysis. Neurocrit Care. 2014 Jun;20(3):514–23. doi:10.1007/s12028-013-9903-5. Cited in PubMed PMID: 24062229. Epub 2013/ 09/26.eng.
   PubMed Web of Science ®Google Scholar
• *Arango MF, Bainbridge D. Magnesium for acute traumatic brain injury. Cochrane Database Syst Rev. 2008 Oct;08(4):CD005400. Cited in PubMed PMID: 18843689. Epub 2008/ 10/10.eng.
   Google Scholar
• *Ker K, Blackhall K. Beta-2 receptor antagonists for acute traumatic brain injury. Cochrane Database Syst Rev. 2008 Jan;23(1):CD006686. Cited in PubMed PMID: 18254109. Epub 2008/ 02/07.eng.
   Google Scholar
• *Deb S, Crownshaw T. The role of pharmacotherapy in the management of behaviour disorders in traumatic brain injury patients. Brain Inj. 2004 Jan;18(1):1–31. doi:10.1080/0269905031000110463. Cited in PubMed PMID: 14660233. Epub 2003/ 12/09.eng.
   PubMed Web of Science ®Google Scholar
• *Fleminger S, Greenwood RJ, Oliver DL. Pharmacological management for agitation and aggression in people with acquired brain injury. Cochrane Database Syst Rev. 2006 Oct;18(4):CD003299. Cited in PubMed PMID: 17054165. Epub 2006/ 10/21.eng.
   Google Scholar
• *Thompson K, Pohlmann-Eden B, Campbell LA, Abel H. Pharmacological treatments for preventing epilepsy following traumatic head injury. Cochrane Database Syst Rev. 2015;8,CD009900.
   PubMed Web of Science ®Google Scholar
• *Adelson PD, Bratton SL, Carney NA, Chesnut RM, Du Coudray HE, Goldstein B, Kochanek PM, Miller HC, Partington MP, Selden NR, et al. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents. Chapter 16. The use of corticosteroids in the treatment of severe pediatric traumatic brain injury. Pediatr Crit Care Med. 2003 Jul;4(3 Suppl):S60–4. Cited in PubMed PMID: 12847352. Epub 2003/ 07/09.eng.
   PubMedGoogle Scholar
• *Yu-Wai-Man P, Griffiths PG. Steroids for traumatic optic neuropathy. Cochrane Database Syst Rev. 2013 Jun;17(6):CD006032. Cited in PubMed PMID: 23771729. Epub 2013/ 06/19.eng.
   Google Scholar
• *Alderson P, Roberts I. Corticosteroids for acute traumatic brain injury. Cochrane Database Syst Rev. 2005 Jan;25(1):CD000196. Cited in PubMed PMID: 15674869. Epub 2005/ 01/28.eng.
   Google Scholar
• *Neugebauer E, Dietrich A, Bouillon B, Lorenz W, Lechleuthner A, Troidl H. Steroids in trauma patients - right or wrong? A qualitative meta-analysis of clinical studies. Theor Surg. 1990;5(1–2):44–53. Cited in PubMed PMID: 27376669. Eng.
   Google Scholar
• *Zhao ZL, Chen X, Zhu H, Zhang BL, Chai Y, Li XY, Dong JF, Zhang JN. Effects of glucocorticoids on traumatic brain injury related critical illness-related corticosteroid insufficiency. Chin Med J (Engl). 2013;126(19):3754–61. Cited in PubMed PMID: 24112177. Epub 2013/10/12. eng.
   PubMed Web of Science ®Google Scholar
• *Roberts I. Aminosteroids for acute traumatic brain injury. Cochrane Database Syst Rev. 2000;4,CD001527.
   PubMedGoogle Scholar
• *Willis C, Lybrand S, Bellamy N. Excitatory amino acid inhibitors for traumatic brain injury. Cochrane Database Syst Rev. 2004;1,CD003986.
   PubMed Web of Science ®Google Scholar
• *Xu D, Huang P, Yu Z, Xing DH, Ouyang S, Xing G. Efficacy and safety of panax notoginseng saponin therapy for acute intracerebral hemorrhage, meta-analysis, and mini review of potential mechanisms of action. Front Neurol. 2014;5:274. Cited in PubMed PMID: 25620952. Pubmed Central PMCID: PMC4288044. Epub 2015/ 01/27.eng.
   PubMed Web of Science ®Google Scholar
• *Comper P, Bisschop SM, Carnide N, Tricco A. A systematic review of treatments for mild traumatic brain injury. Brain Inj. 2005;19(11):863–80.
   PubMed Web of Science ®Google Scholar
• *Gu JW, Yang T, Kuang YQ, Huang HD, Kong B, Shu HF, Yu SX, Zhang JH. Comparison of the safety and efficacy of propofol with midazolam for sedation of patients with severe traumatic brain injury: a meta-analysis. J Crit Care. 2014 Apr;29(2):287–90. doi:10.1016/j.jcrc.2013.10.021. Cited in PubMed PMID: 24360821. Epub 2013/ 12/24.eng.
   PubMed Web of Science ®Google Scholar
• *Roberts I, Sydenham E. Barbiturates for acute traumatic brain injury. Cochrane Database Syst Rev. 2012 Dec 12;12:CD000033. Cited in PubMed PMID: 23235573. Epub 2012/ 12/14.eng.
   PubMedGoogle Scholar
• *Schierhout G, Roberts I. Prophylactic antiepileptic agents after head injury: a systematic review. J Neurol Neurosurg Psychiatry. 1998 Jan;64(1):108–12. Cited in PubMed PMID: 9436738. Pubmed Central PMCID: PMC2169898. Epub 1998/ 01/22.eng.
   PubMed Web of Science ®Google Scholar
• *Zeiler FA, Teitelbaum J, West M, Gillman LM. The ketamine effect on ICP in traumatic brain injury. Neurocrit Care. 2014 Aug;21(1):163–73. doi:10.1007/s12028-013-9950-y. Cited in PubMed PMID: 24515638. Epub 2014/ 02/12.eng.
   PubMed Web of Science ®Google Scholar
• *Beghi E. Overview of studies to prevent posttraumatic epilepsy. Epilepsia. 2003;44 Suppl 10:21–26. doi:10.1046/j.1528-1157.44.s10.1.x. Cited in PubMed PMID: 14511391. Epub 2003/09/27.eng.
   Web of Science ®Google Scholar
• *Chang BS, Lowenstein DH. Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2003 Jan 14;60(1):10–16. Cited in PubMed PMID: 12525711. Epub 2003/ 01/15.eng.
   PubMed Web of Science ®Google Scholar
• *Teasell R, Bayona N, Lippert C, Villamere J, Hellings C. Post-traumatic seizure disorder following acquired brain injury. Brain Inj. 2007 Feb;21(2):201–14. doi:10.1080/02699050701201854. Cited in PubMed PMID: 17364531. Epub 2007/ 03/17.eng.
   PubMed Web of Science ®Google Scholar
• *Fann JR, Hart T, Schomer KG. Treatment for depression after traumatic brain injury: a systematic review. J Neurotrauma. 2009 Dec;26(12):2383–402. doi:10.1089/neu.2009.1091. Cited in PubMed PMID: 19698070. Pubmed Central PMCID: PMC2864457. Epub 2009/ 08/25.eng.
   PubMed Web of Science ®Google Scholar
• *DeMarchi R, Bansal V, Hung A, Wroblewski K, Dua H, Sockalingam S, DeMarchi R, Bansal V, Hung A, Wroblewski K, et al. Review of awakening agents. Can J Neurol Sci. 2005 Feb;32(1):4–17. Cited in PubMed PMID: 15825541. Epub 2005/ 04/14.eng.
   PubMed Web of Science ®Google Scholar
• *Bellamy CJ, Kane-Gill SL, Falcione BA, Seybert AL. Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol. J Trauma. 2009 Mar;66(3):954–58. doi:10.1097/TA.0b013e31818e90ed. Cited in PubMed PMID: 19276778. Epub 2009/ 03/12.eng.
   PubMedGoogle Scholar
• *Gosseries O, Charland-Verville V, Thonnard M, Bodart O, Laureys S, Demertzi A. Amantadine, apomorphine and zolpidem in the treatment of disorders of consciousness. Curr Pharm Des. 2014;20(26):4167–84. Cited in PubMed PMID: 24025057. Epub 2013/ 09/13.eng.
   PubMed Web of Science ®Google Scholar
• *Writer BW, Schillerstrom JE. Psychopharmacological treatment for cognitive impairment in survivors of traumatic brain injury: a critical review. J Neuropsychiatry Clin Neurosci. 2009 Fall;21(4):362–70. doi:10.1176/jnp.2009.21.4.362. Cited in PubMed PMID: 19996244. Epub 2009/ 12/10.eng.
   PubMed Web of Science ®Google Scholar
• *Sawyer E, Mauro LS, Ohlinger MJ. Amantadine enhancement of arousal and cognition after traumatic brain injury. Ann Pharmacother. 2008 Feb;42(2):247–52. doi:10.1345/aph.1K284. Cited in PubMed PMID: 18212258. Epub 2008/ 01/24.eng.
   PubMed Web of Science ®Google Scholar
• *Villareal CL. Amantadine therapy in traumatic brain injury patients. J Pharm Technol. 2007;23(2):93–103.
   Google Scholar
• *Williams SE. Amantadine treatment following traumatic brain injury in children. Brain Inj. 2007 Aug;21(9):885–89. doi:10.1080/02699050701553213. Cited in PubMed PMID: 17729042. Epub 2007/ 08/31.eng.
   PubMed Web of Science ®Google Scholar
• *Frenette AJ, Kanji S, Rees L, Williamson DR, Perreault MM, Turgeon AF, Bernard F, Fergusson DA. Efficacy and safety of dopamine agonists in traumatic brain injury: a systematic review of randomized controlled trials. J Neurotrauma. 2012 Jan 01;29(1):1–18. doi:10.1089/neu.2011.1812. Cited in PubMed PMID: 21846248. Epub 2011/ 08/19.eng.
   PubMed Web of Science ®Google Scholar
• *Sivan M, Neumann V, Kent R, Stroud A, Bhakta BB. Pharmacotherapy for treatment of attention deficits after non-progressive acquired brain injury. A systematic review. Clin Rehabil. 2010 Feb;24(2):110–21. doi:10.1177/0269215509343234. Cited in PubMed PMID: 20103574. Epub 2010/ 01/28.eng.
   PubMed Web of Science ®Google Scholar
• *Backeljauw B, Kurowski BG. Interventions for attention problems after pediatric traumatic brain injury: what is the evidence? Pm & R. 2014 Sep;6(9):814–24. doi:10.1016/j.pmrj.2014.04.004.. Cited in PubMed PMID: 24755513. Pubmed Central PMCID: PMC4177354. Epub 2014/ 04/24.eng
   PubMedGoogle Scholar
• *Godfrey J. Safety of therapeutic methylphenidate in adults: a systematic review of the evidence. J Psychopharmacol. 2009 Mar;23(2):194–205. doi:10.1177/0269881108089809. Cited in PubMed PMID: 18515459. Epub 2008/ 06/03.eng.
   PubMed Web of Science ®Google Scholar
• *Barker-Collo S, Starkey N, Theadom A. Treatment for depression following mild traumatic brain injury in adults: a meta-analysis. Brain Inj. 2013;27(10):1124–33. doi:10.3109/02699052.2013.801513. Cited in PubMed PMID: 23895287. Epub 2013/ 07/31.eng.
   PubMed Web of Science ®Google Scholar
• *Ballesteros J, Guemes I, Ibarra N, Quemada JI. The effectiveness of donepezil for cognitive rehabilitation after traumatic brain injury: a systematic review. J Head Trauma Rehabil. 2008 May-Jun;23(3):171–80. doi:10.1097/01.HTR.0000319935.99837.96. Cited in PubMed PMID: 18520431. Epub 2008/ 06/04.eng.
   PubMed Web of Science ®Google Scholar
• *Poole NA, Agrawal N. Cholinomimetic agents and neurocognitive impairment following head injury: a systematic review. Brain Inj. 2008 Jul;22(7–8):519–34. doi:10.1080/02699050802132495. Cited in PubMed PMID: 18568705. Epub 2008/ 06/24.eng.
   PubMed Web of Science ®Google Scholar
• *Salter KL, McClure JA, Foley NC, Sequeira K, Teasell RW. Pharmacotherapy for depression posttraumatic brain injury: a meta-analysis. J Head Trauma Rehabil. 2016 Jul–Aug;31(4):E21–32. doi:10.1097/HTR.0000000000000193. Cited in PubMed PMID: 26479398. Epub 2015/ 10/20.eng.
   PubMed Web of Science ®Google Scholar
• Azouvi P, Jokic C, Attal N, Denys P, Markabi S, Bussel B. Carbamazepine in agitation and aggressive behaviour following severe closed-head injury: results of an open trial. Brain Inj. 1999 Oct ;13(10):797–804. Cited in PubMed PMID: 10576463. Epub 1999/ 11/27.eng.
   PubMed Web of Science ®Google Scholar
• Brooke MM, Patterson DR, Questad KA, Cardenas D, Farrel-Roberts L. The treatment of agitation during initial hospitalization after traumatic brain injury. Arch Phys Med Rehabil. 1992 Oct ;73(10):917–21. Cited in PubMed PMID: 1417466. Epub 1992/ 10/01.eng.
   PubMed Web of Science ®Google Scholar
• Greendyke RM, Kanter DR. Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: a double-blind study. J Clin Psychiatry. 1986 Aug ;47(8):423–26. Cited in PubMed PMID: 3525523. Epub 1986/ 08/01.eng.
   PubMed Web of Science ®Google Scholar
• Greendyke RM, Kanter DR, Schuster DB, Verstreate S, Wootton J. Propranolol treatment of assaultive patients with organic brain disease. A double-blind crossover, placebo-controlled study. J Nerv Ment Dis. 1986 May ;174(5):290–94. Cited in PubMed PMID: 3517228. Epub 1986/05/01.eng.
   PubMed Web of Science ®Google Scholar
• Chatham-Showalter PE. Carbamazepine for combativeness in acute traumatic brain injury. J Neuropsychiatry Clin Neurosci. 1996 Winter;8(1):96–99. doi:10.1176/jnp.8.1.96. Cited in PubMed PMID: 8845710. Epub 1996/01/01.eng.
   PubMed Web of Science ®Google Scholar
• Chatham Showalter PE, Kimmel DN. Agitated symptom response to divalproex following acute brain injury. J Neuropsychiatry Clin Neurosci. 2000 Summer;12(3):395–97. doi:10.1176/jnp.12.3.395. Cited in PubMed PMID: 10956575. Epub 2000/08/24.eng.
   PubMed Web of Science ®Google Scholar
• Wroblewski BA, Joseph AB, Kupfer J, Kalliel K. Effectiveness of valproic acid on destructive and aggressive behaviours in patients with acquired brain injury. Brain Inj. 1997 Jan ;11(1):37–47. Cited in PubMed PMID: 9012550. Epub 1997/ 01/01.eng.
   PubMed Web of Science ®Google Scholar
• Perino C, Rago R, Cicolini A, Torta R, Monaco F. Mood and behavioural disorders following traumatic brain injury: clinical evaluation and pharmacological management. Brain Inj. 2001 Feb;15(2):139–48. doi:10.1080/026990501458371. Cited in PubMed PMID: 11260764. Epub 2001/ 03/22.eng.
   PubMed Web of Science ®Google Scholar
• Kim E, Humaran TJ. Divalproex in the management of neuropsychiatric complications of remote acquired brain injury. J Neuropsychiatry Clin Neurosci. 2002 Spring;14(2):202–05. doi:10.1176/jnp.14.2.202. Cited in PubMed PMID: 11983796. Epub 2002/05/02.eng.
   PubMed Web of Science ®Google Scholar
• Geracioti TD Jr. Valproic acid treatment of episodic explosiveness related to brain injury. J Clin Psychiatry. 1994 Sep ;55(9):416–17. Cited in PubMed PMID: 7929025. Epub 1994/ 09/01.eng.
   PubMed Web of Science ®Google Scholar
• Newburn G, Edwards R, Thomas H, Collier J, Fox K, Collins C. Moclobemide in the treatment of major depressive disorder (DSM-3) following traumatic brain injury. Brain Inj. 1999 Aug ;13(8):637–42. Cited in PubMed PMID: 10901691. Epub 2000/ 07/20.eng.
   PubMed Web of Science ®Google Scholar
• Rowland TR, Mysiw WJ, Bogner JA, Corrigan JD. Trazadone for post-traumatic agitation. Arch Phys Med Rehabil. 1992;73(10):963.
   Google Scholar
• Michals ML, Crismon ML, Roberts S, Childs A. Clozapine response and adverse effects in nine brain-injured patients. J Clin Psychopharmacol. 1993 Jun ;13(3):198–203. Cited in PubMed PMID: 8354736. Epub 1993/ 06/01.eng.
   PubMed Web of Science ®Google Scholar
• Stanislav SW, Childs A. Evaluating the usage of droperidol in acutely agitated persons with brain injury. Brain Inj. 2000 Mar ;14(3):261–65. Cited in PubMed PMID: 10759043. Epub 2000/ 04/12.eng.
   PubMed Web of Science ®Google Scholar
• Maryniak O, Manchanda R, Velani A. Methotrimeprazine in the treatment of agitation in acquired brain injury patients. Brain Inj. 2001 Feb;15(2):167–74. doi:10.1080/026990501458399. Cited in PubMed PMID: 11260766. Epub 2001/ 03/22.eng.
   PubMed Web of Science ®Google Scholar
• Kim E, Bijlani M. A pilot study of quetiapine treatment of aggression due to traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2006 Fall;18(4):547–49. doi:10.1176/jnp.2006.18.4.547. Cited in PubMed PMID: 17135382. Epub 2006/12/01.eng.
   PubMed Web of Science ®Google Scholar
• Noe E, Ferri J, Trenor C, Chirivella J. Efficacy of ziprasidone in controlling agitation during post-traumatic amnesia. Behav Neurol. 2007;18(1):7–11. Cited in PubMed PMID: 17297214. Pubmed Central PMCID: PMC5469965. Epub 2007/02/14.eng.
   PubMed Web of Science ®Google Scholar
• Schneider WN, Drew-Cates J, Wong TM, Dombovy ML. Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study. Brain Inj. 1999 Nov ;13(11):863–72. Cited in PubMed PMID: 10579658. Epub 1999/ 12/01.eng.
   PubMed Web of Science ®Google Scholar
• Mooney GF, Haas LJ. Effect of methylphenidate on brain injury-related anger. Arch Phys Med Rehabil. 1993 Feb ;74(2):153–60. Cited in PubMed PMID: 8431099. Epub 1993/ 02/01.eng.
   PubMed Web of Science ®Google Scholar
• Gualtieri CT, Evans RW. Stimulant treatment for the neurobehavioural sequelae of traumatic brain injury. Brain Inj. 1988 Oct–Dec ;2(4):273–90. Cited in PubMed PMID: 3060211. Epub 1988/10/01.eng.
   PubMedGoogle Scholar
• Meythaler JM, Brunner RC, Johnson A, Novack TA. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil. 2002 Aug ;17(4):300–13. Cited in PubMed PMID: 12105999. Epub 2002/ 07/11.eng.
   PubMed Web of Science ®Google Scholar
• Kant R, Smith-Seemiller L, Zeiler D. Treatment of aggression and irritability after head injury. Brain Inj. 1998 Aug ;12(8):661–66. Cited in PubMed PMID: 9724837. Epub 1998/ 09/02.eng.
   PubMed Web of Science ®Google Scholar
• Fann JR, Uomoto JM, Katon WJ. Sertraline in the treatment of major depression following mild traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2000 Spring;12(2):226–32. doi:10.1176/jnp.12.2.226. Cited in PubMed PMID: 11001601. Epub 2000/09/23.eng.
   PubMed Web of Science ®Google Scholar
• Knoller N, Levi L, Shoshan I, Reichenthal E, Razon N, Rappaport ZH, Biegon A. Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial. Crit Care Med. 2002 Mar;30(3):548–54. Cited in PubMed PMID: 11990913. Epub 2002/ 05/07.eng.
   PubMed Web of Science ®Google Scholar
• Maas AI, Murray G, Henney H 3rd, Kassem N, Legrand V, Mangelus M, Muizelaar JP, Stocchetti N, Knoller N, Pharmos TBI investigators. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol. 2006 Jan;5(1):38–45. doi:10.1016/S1474-4422(05)70253-2. Cited in PubMed PMID: 16361021. Epub 2005/ 12/20.eng.
   PubMed Web of Science ®Google Scholar
• Walker W, Seel R, Gibellato M, Lew H, Cornis-Pop M, Jena T, Silver T. The effects of donepezil on traumatic brain injury acute rehabilitation outcomes. Brain Inj. 2004 Aug;18(8):739–50. doi:10.1080/02699050310001646224. Cited in PubMed PMID: 15204315. Epub 2004/ 06/19.eng.
   PubMed Web of Science ®Google Scholar
• Khateb A, Ammann J, Annoni JM, Diserens K. Cognition-enhancing effects of donepezil in traumatic brain injury. Eur Neurol. 2005;54(1):39–45. doi:10.1159/000087718. Cited in PubMed PMID: 16118495. Epub 2005/08/25.eng.
   PubMed Web of Science ®Google Scholar
• Masanic CA, Bayley MT, VanReekum R, Simard M. Open-label study of donepezil in traumatic brain injury. Arch Phys Med Rehabil. 2001 Jul;82(7):896–901. doi:10.1053/apmr.2001.23833. Cited in PubMed PMID: 11441374. Epub 2001/ 07/07.eng.
   PubMed Web of Science ®Google Scholar
• Wu TS, Garmel GM. Improved neurological function after amantadine treatment in two patients with brain injury. J Emerg Med. 2005 Apr;28(3):289–92. doi:10.1016/j.jemermed.2004.11.016. Cited in PubMed PMID: 15769570. Epub 2005/ 03/17.eng.
   PubMed Web of Science ®Google Scholar
• Zafonte RD, Watanabe T, Mann NR. Amantadine: a potential treatment for the minimally conscious state. Brain Inj. 1998 Jul ;12(7):617–21. Cited in PubMed PMID: 9653525. Epub 1998/ 07/08.eng.
   PubMed Web of Science ®Google Scholar
• Sharif MO, Janjua-Sharif FN, Ali H, Ahmed F. Systematic reviews explained: AMSTAR-how to tell the good from the bad and the ugly. Oral Health Dent Manag. 2013 Mar ;12(1):9–16. Cited in PubMed PMID: 23474576. Epub 2013/ 03/12.eng.
   PubMedGoogle Scholar
• Hart T, Fann JR, Chervoneva I, Juengst SB, Rosenthal JA, Krellman JW, Dreer LE, Kroenke K. Prevalence, risk factors, and correlates of anxiety at 1 year after moderate to severe traumatic brain injury. Arch Phys Med Rehabil. 2016 May;97(5):701–07. doi:10.1016/j.apmr.2015.08.436. Cited in PubMed PMID: 26707456. Epub 2015/ 12/29.eng.
   PubMed Web of Science ®Google Scholar
• Sashika H, Takada K, Kikuchi N. Rehabilitation needs and participation restriction in patients with cognitive disorder in the chronic phase of traumatic brain injury. Medicine (Baltimore). 2017 Jan;96(4):e5968. doi:10.1097/MD.0000000000005968. Cited in PubMed PMID: 28121947. Pubmed Central PMCID: PMC5287971. Epub 2017/ 01/26.eng.
   PubMed Web of Science ®Google Scholar
• Rabinowitz AR, Levin HS. Cognitive sequelae of traumatic brain injury. Psychiatr Clin North Am. 2014 Mar;37(1):1–11. doi:10.1016/j.psc.2013.11.004. Cited in PubMed PMID: 24529420. Pubmed Central PMCID: PMC3927143. Epub 2014/02/18.eng.
   PubMed Web of Science ®Google Scholar
• Lew HL, Poole JH, Guillory SB, Salerno RM, Leskin G, Sigford B. Persistent problems after traumatic brain injury: the need for long-term follow-up and coordinated care. J Rehabil Res Dev. 2006 Mar–Apr ;43(2):vii–x. Cited in PubMed PMID: 16847779. Epub 2006/ 07/19.eng.
   PubMedGoogle Scholar
• McAllister TW. Neurobehavioral sequelae of traumatic brain injury: evaluation and management. World Psychiatry. 2008 Feb ;7(1):3–10. Cited in PubMed PMID: 18458777. Pubmed Central PMCID: PMC2327235. Epub 2008/ 05/07.eng.
   PubMed Web of Science ®Google Scholar
• Winkler D, Unsworth C, Sloan S. Factors that lead to successful community integration following severe traumatic brain injury. J Head Trauma Rehabil. 2006 Jan–Feb;21(1):8–21. Cited in PubMed PMID: 16456388. Epub 2006/02/04.eng.
   PubMed Web of Science ®Google Scholar
• Ponsford JL, Ziino C, Parcell DL, Shekleton JA, Roper M, Redman JR, Phipps-Nelson J, Rajaratnam SM. Fatigue and sleep disturbance following traumatic brain injury–their nature, causes, and potential treatments. J Head Tra-uma Rehabil. 2012 May–Jun;27(3):224–33. doi:10.1097/HTR.0b013e31824ee1a8. Cited in PubMed PMID: 22573041. Epub 2012/05/11.eng.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Rates of TBI-related Deaths by Age Group — United States, 2001–2010. [Internet]. Atlanta, GA: U.S. Department of Health & Human Services [cited 2019 Jan 8]. Available from: https://www.cdc.gov/traumaticbraininjury/data/rates_deaths_byage.html
   Google Scholar
• Masel BE, DeWitt DS. Traumatic brain injury: a disease process, not an event. J Neurotrauma. 2010;27(8):1529–40. doi:10.1089/neu.2010.1358.
   PubMed Web of Science ®Google Scholar
• Zaloshnja E, Miller T, Langlois JA, Selassie AW. Prevalence of long-term disability from traumatic brain injury in the civilian population of the United States, 2005. J Head Trauma Rehabil. 2008 Nov–Dec;23(6):394–400. doi:10.1097/01.HTR.0000341435.52004.ac. Cited in PubMed PMID: 19033832. Epub 2008/11/27.eng.
   PubMed Web of Science ®Google Scholar
• Roy D, Koliatsos V, Vaishnavi S, Han D, Rao V. Risk Factors for New-Onset Depression After First-Time Traumatic Brain Injury. Psychosomatics. 2018;59(1):47–57. doi:10.1016/j.psym.2017.07.008. Cited in PubMed PMID: 28844451; PubMed Central PMCID: PMC5747996.
   PubMed Web of Science ®Google Scholar
• Khan F, Amatya B, Judson R, Chung P, Truesdale M, Elmalik A, Galea MP. Factors associated with long-term functional and psychological outcomes in persons with moderate to severe traumatic brain injury. J Rehabil Med. 2016 Apr 28;48(5):442–48. doi:10.2340/16501977-2084. Cited in PubMed PMID: 27058885. Epub 2016/04/09.eng.
   PubMed Web of Science ®Google Scholar
• Heinemann AW, Magasi S, Bode RK, Hammel J, Whiteneck GG, Bogner J, Corrigan JD. Measuring enfranchisement: importance of and control over participation by people with disabilities. Arch Phys Med Rehabil. 2013 Nov;94(11):2157–65. doi:10.1016/j.apmr.2013.05.017. Cited in PubMed PMID: 23769764. Epub 2013/ 06/19.eng.
   PubMed Web of Science ®Google Scholar
• International Classification of Functioning, Disability and Health (short version). Geneva: World Health Organization. 2017. [updated 2018 March 2; cited 2019 Jan 8]. Available from: https://www.who.int/classifications/icf/en/.
   Google Scholar
• Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, Porter AC, Tugwell P, Moher D, Bouter LM.Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007 Feb 15;7:10. doi:10.1186/1471-2288-7-10. Cited in PubMed PMID: 17302989. Pubmed Central PMCID: PMC1810543. Epub 2007/ 02/17.eng.
   PubMed Web of Science ®Google Scholar